nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—myometrium—ovarian cancer	0.0571	0.116	CbGeAlD
Framycetin—CXCR4—embryo—ovarian cancer	0.0549	0.112	CbGeAlD
Framycetin—Ototoxicity—Vinorelbine—ovarian cancer	0.0451	0.116	CcSEcCtD
Framycetin—CXCR4—epithelium—ovarian cancer	0.0448	0.091	CbGeAlD
Framycetin—CXCR4—uterine cervix—ovarian cancer	0.0444	0.0903	CbGeAlD
Framycetin—CXCR4—decidua—ovarian cancer	0.0423	0.086	CbGeAlD
Framycetin—CXCR4—endometrium—ovarian cancer	0.0402	0.0816	CbGeAlD
Framycetin—CXCR4—uterus—ovarian cancer	0.037	0.0752	CbGeAlD
Framycetin—CXCR4—female reproductive system—ovarian cancer	0.0333	0.0676	CbGeAlD
Framycetin—CXCR4—bone marrow—ovarian cancer	0.0314	0.0638	CbGeAlD
Framycetin—Ototoxicity—Paclitaxel—ovarian cancer	0.0303	0.078	CcSEcCtD
Framycetin—CXCR4—female gonad—ovarian cancer	0.0303	0.0615	CbGeAlD
Framycetin—CXCR4—vagina—ovarian cancer	0.0301	0.0612	CbGeAlD
Framycetin—Nerve injury—Paclitaxel—ovarian cancer	0.0279	0.0717	CcSEcCtD
Framycetin—CXCR4—testis—ovarian cancer	0.0269	0.0546	CbGeAlD
Framycetin—Ototoxicity—Docetaxel—ovarian cancer	0.0257	0.0661	CcSEcCtD
Framycetin—Impaired healing—Melphalan—ovarian cancer	0.0239	0.0616	CcSEcCtD
Framycetin—CXCR4—lymph node—ovarian cancer	0.0195	0.0396	CbGeAlD
Framycetin—Nephropathy toxic—Vinorelbine—ovarian cancer	0.0158	0.0405	CcSEcCtD
Framycetin—Secondary infection—Epirubicin—ovarian cancer	0.0118	0.0304	CcSEcCtD
Framycetin—Secondary infection—Doxorubicin—ovarian cancer	0.011	0.0282	CcSEcCtD
Framycetin—Nephropathy toxic—Paclitaxel—ovarian cancer	0.0106	0.0273	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—CHMP4C—ovarian cancer	0.0106	0.0891	CbGpPWpGaD
Framycetin—Sensitisation—Epirubicin—ovarian cancer	0.00974	0.0251	CcSEcCtD
Framycetin—Sensitisation—Doxorubicin—ovarian cancer	0.00901	0.0232	CcSEcCtD
Framycetin—Infection—Carboplatin—ovarian cancer	0.00819	0.0211	CcSEcCtD
Framycetin—Vomiting—Altretamine—ovarian cancer	0.00758	0.0195	CcSEcCtD
Framycetin—CXCR4—HIV Infection—CHMP4C—ovarian cancer	0.00731	0.0615	CbGpPWpGaD
Framycetin—Nausea—Altretamine—ovarian cancer	0.00708	0.0182	CcSEcCtD
Framycetin—Viral infection—Paclitaxel—ovarian cancer	0.00674	0.0173	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—SLC2A1—ovarian cancer	0.00632	0.0532	CbGpPWpGaD
Framycetin—Swelling—Paclitaxel—ovarian cancer	0.00501	0.0129	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ABCB1—ovarian cancer	0.00499	0.042	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—VEGFA—ovarian cancer	0.00467	0.0393	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—MAPK3—ovarian cancer	0.00442	0.0372	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—MMP9—ovarian cancer	0.00427	0.036	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—TERT—ovarian cancer	0.00427	0.0359	CbGpPWpGaD
Framycetin—Swelling—Docetaxel—ovarian cancer	0.00424	0.0109	CcSEcCtD
Framycetin—Infection—Chlorambucil—ovarian cancer	0.00421	0.0108	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—MAPK1—ovarian cancer	0.00421	0.0354	CbGpPWpGaD
Framycetin—Erythema—Vinorelbine—ovarian cancer	0.00396	0.0102	CcSEcCtD
Framycetin—Viral infection—Epirubicin—ovarian cancer	0.00385	0.00991	CcSEcCtD
Framycetin—Anaphylactic shock—Topotecan—ovarian cancer	0.00377	0.0097	CcSEcCtD
Framycetin—Infection—Topotecan—ovarian cancer	0.00375	0.00964	CcSEcCtD
Framycetin—Anaphylactic shock—Melphalan—ovarian cancer	0.00369	0.0095	CcSEcCtD
Framycetin—Infection—Melphalan—ovarian cancer	0.00367	0.00944	CcSEcCtD
Framycetin—Viral infection—Doxorubicin—ovarian cancer	0.00356	0.00917	CcSEcCtD
Framycetin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00323	0.0083	CcSEcCtD
Framycetin—Infection—Vinorelbine—ovarian cancer	0.00321	0.00825	CcSEcCtD
Framycetin—Hypersensitivity—Chlorambucil—ovarian cancer	0.00312	0.00803	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—ovarian cancer	0.00302	0.0254	CbGpPWpGaD
Framycetin—Pruritus—Chlorambucil—ovarian cancer	0.003	0.00771	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—AKT1—ovarian cancer	0.00298	0.0251	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CG—ovarian cancer	0.00296	0.0249	CbGpPWpGaD
Framycetin—Diarrhoea—Chlorambucil—ovarian cancer	0.0029	0.00746	CcSEcCtD
Framycetin—Hypersensitivity—Topotecan—ovarian cancer	0.00278	0.00715	CcSEcCtD
Framycetin—Hypersensitivity—Melphalan—ovarian cancer	0.00272	0.007	CcSEcCtD
Framycetin—Vomiting—Chlorambucil—ovarian cancer	0.0027	0.00693	CcSEcCtD
Framycetin—Pruritus—Topotecan—ovarian cancer	0.00267	0.00687	CcSEcCtD
Framycetin—Erythema—Paclitaxel—ovarian cancer	0.00266	0.00684	CcSEcCtD
Framycetin—Pruritus—Melphalan—ovarian cancer	0.00261	0.00672	CcSEcCtD
Framycetin—Diarrhoea—Topotecan—ovarian cancer	0.00258	0.00664	CcSEcCtD
Framycetin—Diarrhoea—Melphalan—ovarian cancer	0.00253	0.0065	CcSEcCtD
Framycetin—Nausea—Chlorambucil—ovarian cancer	0.00252	0.00648	CcSEcCtD
Framycetin—Vomiting—Topotecan—ovarian cancer	0.0024	0.00617	CcSEcCtD
Framycetin—Hypersensitivity—Vinorelbine—ovarian cancer	0.00238	0.00612	CcSEcCtD
Framycetin—Vomiting—Melphalan—ovarian cancer	0.00235	0.00604	CcSEcCtD
Framycetin—Pruritus—Vinorelbine—ovarian cancer	0.00228	0.00587	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CB—ovarian cancer	0.00227	0.0191	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—MTOR—ovarian cancer	0.00227	0.0191	CbGpPWpGaD
Framycetin—Erythema—Docetaxel—ovarian cancer	0.00226	0.0058	CcSEcCtD
Framycetin—Nausea—Topotecan—ovarian cancer	0.00224	0.00576	CcSEcCtD
Framycetin—CXCR4—Disease—HSD17B6—ovarian cancer	0.00224	0.0189	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—ovarian cancer	0.00222	0.0187	CbGpPWpGaD
Framycetin—Diarrhoea—Vinorelbine—ovarian cancer	0.00221	0.00568	CcSEcCtD
Framycetin—Nausea—Melphalan—ovarian cancer	0.00219	0.00564	CcSEcCtD
Framycetin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00217	0.00558	CcSEcCtD
Framycetin—Infection—Paclitaxel—ovarian cancer	0.00216	0.00555	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	0.00215	0.0181	CbGpPWpGaD
Framycetin—Vomiting—Vinorelbine—ovarian cancer	0.00205	0.00528	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—ovarian cancer	0.00197	0.0166	CbGpPWpGaD
Framycetin—Nausea—Vinorelbine—ovarian cancer	0.00192	0.00493	CcSEcCtD
Framycetin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00184	0.00473	CcSEcCtD
Framycetin—Infection—Docetaxel—ovarian cancer	0.00183	0.0047	CcSEcCtD
Framycetin—CXCR4—Disease—CHMP4C—ovarian cancer	0.00179	0.0151	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—ovarian cancer	0.00176	0.0148	CbGpPWpGaD
Framycetin—Hypersensitivity—Paclitaxel—ovarian cancer	0.0016	0.00411	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—HSD17B6—ovarian cancer	0.00157	0.0132	CbGpPWpGaD
Framycetin—CXCR4—Disease—BCL9—ovarian cancer	0.00155	0.0131	CbGpPWpGaD
Framycetin—Pruritus—Paclitaxel—ovarian cancer	0.00154	0.00395	CcSEcCtD
Framycetin—Erythema—Epirubicin—ovarian cancer	0.00152	0.00391	CcSEcCtD
Framycetin—Diarrhoea—Paclitaxel—ovarian cancer	0.00149	0.00382	CcSEcCtD
Framycetin—Erythema—Doxorubicin—ovarian cancer	0.00141	0.00362	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—ovarian cancer	0.00138	0.0117	CbGpPWpGaD
Framycetin—Vomiting—Paclitaxel—ovarian cancer	0.00138	0.00355	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	0.00137	0.0115	CbGpPWpGaD
Framycetin—Hypersensitivity—Docetaxel—ovarian cancer	0.00136	0.00349	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—DLC1—ovarian cancer	0.00133	0.0112	CbGpPWpGaD
Framycetin—Pruritus—Docetaxel—ovarian cancer	0.0013	0.00335	CcSEcCtD
Framycetin—Nausea—Paclitaxel—ovarian cancer	0.00129	0.00332	CcSEcCtD
Framycetin—Diarrhoea—Docetaxel—ovarian cancer	0.00126	0.00324	CcSEcCtD
Framycetin—Anaphylactic shock—Epirubicin—ovarian cancer	0.00124	0.00319	CcSEcCtD
Framycetin—Infection—Epirubicin—ovarian cancer	0.00123	0.00317	CcSEcCtD
Framycetin—Vomiting—Docetaxel—ovarian cancer	0.00117	0.00301	CcSEcCtD
Framycetin—CXCR4—Disease—PPP1CC—ovarian cancer	0.00115	0.00971	CbGpPWpGaD
Framycetin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00115	0.00295	CcSEcCtD
Framycetin—Infection—Doxorubicin—ovarian cancer	0.00114	0.00293	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—ovarian cancer	0.00114	0.00956	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—ovarian cancer	0.00113	0.00952	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—ovarian cancer	0.00109	0.00281	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—BCL9—ovarian cancer	0.00109	0.00915	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—ovarian cancer	0.000958	0.00807	CbGpPWpGaD
Framycetin—Hypersensitivity—Epirubicin—ovarian cancer	0.000915	0.00235	CcSEcCtD
Framycetin—Pruritus—Epirubicin—ovarian cancer	0.000878	0.00226	CcSEcCtD
Framycetin—CXCR4—Disease—HDAC6—ovarian cancer	0.000875	0.00736	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DOK1—ovarian cancer	0.00086	0.00723	CbGpPWpGaD
Framycetin—Diarrhoea—Epirubicin—ovarian cancer	0.000849	0.00218	CcSEcCtD
Framycetin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000846	0.00218	CcSEcCtD
Framycetin—Pruritus—Doxorubicin—ovarian cancer	0.000813	0.00209	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PPP1CC—ovarian cancer	0.000808	0.0068	CbGpPWpGaD
Framycetin—Vomiting—Epirubicin—ovarian cancer	0.000789	0.00203	CcSEcCtD
Framycetin—Diarrhoea—Doxorubicin—ovarian cancer	0.000786	0.00202	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—ovarian cancer	0.000762	0.00641	CbGpPWpGaD
Framycetin—CXCR4—Disease—XIAP—ovarian cancer	0.000758	0.00638	CbGpPWpGaD
Framycetin—CXCR4—Disease—SMARCA4—ovarian cancer	0.000739	0.00622	CbGpPWpGaD
Framycetin—Nausea—Epirubicin—ovarian cancer	0.000737	0.0019	CcSEcCtD
Framycetin—Vomiting—Doxorubicin—ovarian cancer	0.00073	0.00188	CcSEcCtD
Framycetin—CXCR4—Disease—EREG—ovarian cancer	0.000721	0.00607	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—ovarian cancer	0.000682	0.00175	CcSEcCtD
Framycetin—CXCR4—Disease—FASN—ovarian cancer	0.000631	0.00531	CbGpPWpGaD
Framycetin—CXCR4—Disease—PARP1—ovarian cancer	0.000628	0.00529	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HDAC6—ovarian cancer	0.000613	0.00515	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000604	0.00508	CbGpPWpGaD
Framycetin—CXCR4—Disease—SLC2A1—ovarian cancer	0.000599	0.00504	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—ovarian cancer	0.00058	0.00488	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—YAP1—ovarian cancer	0.000542	0.00456	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—XIAP—ovarian cancer	0.000531	0.00447	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SMARCA4—ovarian cancer	0.000518	0.00436	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPP2R1A—ovarian cancer	0.00051	0.00429	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EREG—ovarian cancer	0.000505	0.00425	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PGR—ovarian cancer	0.000473	0.00398	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000445	0.00375	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PARP1—ovarian cancer	0.00044	0.0037	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6ST—ovarian cancer	0.000421	0.00354	CbGpPWpGaD
Framycetin—CXCR4—Disease—TERT—ovarian cancer	0.000405	0.00341	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—ovarian cancer	0.000404	0.0034	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000392	0.00329	CbGpPWpGaD
Framycetin—CXCR4—Disease—CAV1—ovarian cancer	0.000375	0.00315	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PPP2R1A—ovarian cancer	0.000357	0.003	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CD—ovarian cancer	0.000356	0.00299	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6ST—ovarian cancer	0.000355	0.00299	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000341	0.00287	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—ovarian cancer	0.000341	0.00287	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—ovarian cancer	0.000328	0.00276	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—ovarian cancer	0.000313	0.00264	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CB—ovarian cancer	0.00031	0.00261	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CD—ovarian cancer	0.0003	0.00252	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—ovarian cancer	0.000298	0.00251	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—ovarian cancer	0.000285	0.0024	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TERT—ovarian cancer	0.000284	0.00239	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—ovarian cancer	0.000265	0.00223	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CAV1—ovarian cancer	0.000262	0.00221	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CB—ovarian cancer	0.000261	0.0022	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTOR—ovarian cancer	0.000261	0.0022	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ESR1—ovarian cancer	0.000253	0.00213	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6ST—ovarian cancer	0.000249	0.00209	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1B—ovarian cancer	0.000245	0.00206	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—ovarian cancer	0.000239	0.00201	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—ovarian cancer	0.000239	0.00201	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NRAS—ovarian cancer	0.000239	0.00201	CbGpPWpGaD
Framycetin—CXCR4—Disease—CTNNB1—ovarian cancer	0.000232	0.00195	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—ovarian cancer	0.000229	0.00193	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—ovarian cancer	0.000226	0.0019	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK1—ovarian cancer	0.000218	0.00183	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—ovarian cancer	0.000218	0.00183	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CD—ovarian cancer	0.00021	0.00177	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000208	0.00175	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—ovarian cancer	0.000206	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—ovarian cancer	0.000202	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRAS—ovarian cancer	0.000202	0.0017	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—ovarian cancer	0.000193	0.00162	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—ovarian cancer	0.000189	0.00159	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—ovarian cancer	0.000188	0.00158	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—ovarian cancer	0.000186	0.00156	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK1—ovarian cancer	0.000184	0.00155	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—ovarian cancer	0.000184	0.00155	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CB—ovarian cancer	0.000183	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MTOR—ovarian cancer	0.000183	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—ovarian cancer	0.000176	0.00148	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—ovarian cancer	0.000175	0.00147	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—ovarian cancer	0.000173	0.00146	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1B—ovarian cancer	0.000172	0.00145	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—ovarian cancer	0.00017	0.00143	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—ovarian cancer	0.000168	0.00142	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—ovarian cancer	0.000168	0.00141	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—ovarian cancer	0.000167	0.00141	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—ovarian cancer	0.000164	0.00138	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CTNNB1—ovarian cancer	0.000162	0.00137	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—ovarian cancer	0.000159	0.00134	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—ovarian cancer	0.000159	0.00134	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—ovarian cancer	0.000158	0.00133	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—ovarian cancer	0.000154	0.0013	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—ovarian cancer	0.000147	0.00124	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—ovarian cancer	0.000143	0.0012	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—ovarian cancer	0.000141	0.00119	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRAS—ovarian cancer	0.000141	0.00119	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—ovarian cancer	0.000141	0.00119	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—ovarian cancer	0.000135	0.00114	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—ovarian cancer	0.000131	0.00111	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—ovarian cancer	0.00013	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK1—ovarian cancer	0.000129	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—ovarian cancer	0.000129	0.00108	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—ovarian cancer	0.000121	0.00102	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—ovarian cancer	0.000112	0.000939	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—ovarian cancer	0.000108	0.000909	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—ovarian cancer	0.000103	0.000869	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—ovarian cancer	9.88e-05	0.000832	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—ovarian cancer	9.12e-05	0.000767	CbGpPWpGaD
